Effects of long-term ouabain treatment on blood pressure, sodium excretion, and renal dopamine D1 receptor levels in rats

Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology

Volumn 180, Issue 1, 2010, Pages 117-124

  Zhang, Yurong ^a   Yuan, Zuyi ^a   Ge, Heng ^a   Ren, Yanping ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hypertension; Na+ K+ ATPase; Ouabain; Renal dopamine D1 receptor; Sodium transport

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; OUABAIN; SODIUM;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CELL LINE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EPITHELIUM CELL; HUMAN; KIDNEY; KIDNEY PROXIMAL TUBULE; MALE; METABOLISM; PHOSPHORYLATION; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; TIME; URINE;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CELL LINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; OUABAIN; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIME FACTORS;

RATTUS; STROPHANTHUS GRATUS;

EID: 73949133925     PISSN: 01741578     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00360-009-0391-z     Document Type: Article

References (31)

1. Aperia A (2001) Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility. Curr Hypertens Rep 3: 165-171.
2. Barnard ML, Olivera WG, Rutschman DM, Bertorello AM, Katz AI, Sznajder JI (1997) Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium. Am J Respir Crit Care Med 156: 709-714.
3. Boireau A, Meunier M, Imperato A (1998) Ouabain-induced increase in dopamine release from mouse striatal slices is antagonized by riluzole. J Pharm Pharmacol 50: 1293-1297.
4. Cargnelli G, Trevisi L, Debetto P, Luciani S, Bova S (2000) Effect of long-term ouabain treatment on contractile responses of rat aortae. J Cardiovasc Pharmacol 35: 538-542.
5. Diniz PH, Silva JH, Gomez MV, Guatimosim C, Gomez RS (2007) Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices. Cell Mol Neurobiol 27: 757-770.
6. Doris PA (2000) Renal proximal tubule sodium transport and genetic mechanisms of essential hypertension. J Hypertens 18: 509-519.
7. Eklof AC, Holtback U, Sundelof M, Chen S, Aperia A (1997) Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+, K+-ATPase. Kidney Int 52: 742-747.
8. Felder RA, Eisner GM, Jose PA (2000) D1 dopamine receptor signaling defect in spontaneous hypertension. Acta Physiol Scand 168: 245-250.
9. Ferrandi M, Manunta P (2000) Ouabain-like factor: is this the natriuretic hormone. Curr Opin Nephrol Hypertens 9: 165-171.
10. Ferrandi M, Barassi P, Molinari I, Torielli L, Tripodi G, Minotti E, Bianchi G, Ferrari P (2005) Ouabain antagonists as antihypertensive agents. Curr Pharm Des 11: 3301-3305.
11. Ferrari P, Torielli L, Ferrandi M, Padoani G, Duzzi L, Florio M, Conti F, Melloni P, Vesci L, Corsico N, Bianchi G (1998) PST 2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. J Pharmacol Exp Ther 285: 83-94.
12. Ge H, Lü ZR (2006) Changes in renal sodium transport during hypertension development in ouabain-hypertensive rats. Nan Fang Yi Ke Da Xue Xue Bao 26: 1404-1407.
13. Hamlyn JM, Hamilton BP, Manunta P (1996) Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 14: 151-167.
14. Huang BS, Leenen FH (1999) Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 34: 107-112.
15. Jose PA, Eisner GM, Felder RA (2000) Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2: 174-183.
16. Jose PA, Eisner GM, Felder RA (2002) Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11: 87-92.
17. Ladines CA, Zeng C, Asico LD, Sun X, Pocchiari F, Semeraro C, Pisegna J, Wank S, Yamaguchi I, Eisner GM, Jose PA (2001) Impaired renal D(1)-like and D(2)-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 281: R1071-R1078.
18. Li M, Martin A, Wen C, Turner SW, Lewis LK, Whitworth JA (1995) Long-term ouabain administration does not alter blood pressure in conscious Sprague-Dawley rats. Clin Exp Pharmacol Physiol 22: 919-923.
19. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM (1994) Ouabain induced hypertension in the rat: relationship among plasma and tissue ouabain and blood pressure. J Hypertens 12: 549-560.
20. Manunta P, Messaggio E, Ballabeni C, Sciarrone MT, Lanzanic C, Ferrandi M, Hamlyn JM, Cusi D, Galletti G, Salt Sensitivity Study Group of the Italian Society of Hypertension (2001) Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 38: 198-203.
21. Manunta P, Ferrandi M, Messaggio E, Ferrari P (2006) A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin. Cardiovasc Hematol Agents Med Chem 4: 61-66.
22. Manunta P, Maillard M, Tantardini C, Simonini M, Lanzani C, Citterio L, Stella P, Casamassima N, Burnier M, Hamlyn JM, Bianchi G (2008) Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J Hypertens 26: 914-920.
23. Marwaha A, Banday AA, Lokhandwala MF (2004) Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 286: F451-F457.
24. Rossoni LV, Cunha V, Franca A, Vassallo DV (1999) The influence of nanomolar ouabain on vascular pressor responses is modulated by the endothelium. J Cardiovasc Pharmacol 34: 887-892.
25. Rossoni LV, Salaices M, Marín J, Vassallo DV, Alonso MJ (2002a) Alterations in phenylephrine-induced contractions and the vascular expression of Na+, K+- ATPase in ouabain-induced hypertension. Br J Pharmacol 135: 771-781.
26. Rossoni LV, Salaices M, Miguel M, Briones AM, Barker LA, Vassallo DV, Alonso MJ (2002b) Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am J Physiol Heart Circ Physiol 283: H2110-H2118.
27. Rossoni LV, Xavier FE, Moreira CM, Falcochio D, Amanso AM, Tanoue CU, Carvalho CR, Vassallo DV (2006) Ouabain-induced hypertension enhances left ventricular contractility in rats. Life Sci 79: 1537-1545.
28. Sanada H, Jose PA, Harzen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA (1999) Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33: 1036-1042.
29. Schoner W (2002) Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269: 2440-2448.
30. Schoner W, Scheiner-Bobis G (2007) Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293: C509-C536.
31. +-ATPase alpha-subunit in ouabain-hypertensive rats. Hypertens Res 24: 729-734.